Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sarcona convicted in supplement scam

This article was originally published in The Tan Sheet

Executive Summary

A federal jury convicts Frank Sarcona, a Boca Raton, Fla., businessman of defrauding more than 100,000 consumers out of more than $16 million "through his fraudulent sales techniques" relating to a supplement product called Lipoban, says Jeffrey Sloman, U.S. Attorney for the Southern District of Florida. Sarcona's sentencing is scheduled for Jan. 15, 2010. Sloman's Oct. 30 release says Sarcona - also known as Frank Sarcone and Dave Johnson - violated a 1999 final injunction order prohibiting his connection with the sale of a supplement and requiring him to post a $5 million performance bond before becoming involved with a weight-loss service or product. The injunction order stemmed from the lawsuit FTC v. SlimAmerica (1"The Tan Sheet" Feb. 10, 1997)
Advertisement

Related Content

SlimAmerica Super Formula weight loss products target of FTC suit.
SlimAmerica Super Formula weight loss products target of FTC suit.

Topics

Advertisement
UsernamePublicRestriction

Register

PS103510

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel